QC
IRMD icon

Quadrature Capital’s iRadimed IRMD Stock Holding History

Quadrature Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Buy
+12,215
New +$1.11M 0.01% 689
2025
Q4 		– Sell
-3,234
Closed -$230K – 1458
2025
Q3 		$230K Sell
3,234
-1,202
-27% -$80.1K ﹤0.01% 746
2025
Q2 		$265K Buy
+4,436
New +$243K ﹤0.01% 730

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quadrature Capital's IRMD Position: Q2 2026 in Review

Quadrature Capital opened a new position in iRadimed (IRMD) in Q2 2026: 12,215 shares worth $1.17M. The stake represents 0.01% of the portfolio and ranks #689 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in IRMD as recently as Q3 2025.

Quadrature Capital first reported a position in IRMD in Q2 2025 and has held it in 3 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Quadrature Capital held 12,215 shares of iRadimed worth $1.17M as of Q2 2026.
  • iRadimed was a new Quadrature Capital position in Q2 2026.
  • iRadimed made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #689 holding.
  • Quadrature Capital first reported a position in iRadimed in Q2 2025 and has held it in 3 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.